Wee Yao Koh

Dr Koh Wee Yao is a Senior Consultant at the Department of Radiation Oncology at the NCIS. He is also the breast cancer Lead for radiation onclogy as well as an Assistant Professor at the NUS.

Designations:

• Senior Consultant, Department of Radiation Oncology, National University Cancer Institute, Singapore
• Education Director, Department of Radiation Oncology, National University Cancer Institute, Singapore
• Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore

Specialties:

Radiation Oncology

Education

• Fellow of the Royal Australian and New Zealand College of Radiologists Royal Australian and New Zealand College of Radiologists (2005 — 2009)
• Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) National University of Singapore (1996 — 2000)
• National Junior College Singapore (1994 — 1995)

Companies

• Senior Consultant National University Hospital (2018)
• Visiting Consultant National Neuroscience Institute (2009)
• Consultant Tan Tock Seng Hospital (2009)
• Consultant National University Health System (2009)
• Assistant Professor National University of Singapore (2008)
• Registrar National University Health System (2005 — 2009)
• Medical Officer National Cancer Centre Singapore (2004 — 2005)
• Intern Ministry of Health Singapore (2000 — 2001)

Special Interests:

Breast cancer, Lung cancer, Central Nervous System cancers

Awards

• Higher Manpower Development Plan Award, Liverpool Hospital - 2008
• NUHS Academic Medicine Development Award - 2012

Journals & Publications

​1. Soon YY, Leong CN, Koh WY, Tham IW. EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis.Radiother Oncol. 2015 Feb;114(2):167-72. doi: 10.1016/j.radonc.2014.12.011. Epub 2015 Jan 9. Review.

1. Vellayappan BA, Soon YY, Earnest A, Zhang Q, Koh WY, Tham IW, Lee KM. Accuracy of (18)F-flurodeoxyglucose-positron emission tomography/computed tomography in the staging of newly diagnosed nasopharyngeal carcinoma: a systematic review and meta-analysis. Radiol Oncol. 2014 Nov 5;48(4):331-8. doi: 10.2478/raon-2014-0011. eCollection 2014 Dec.

2. Tey J, Choo BA, Leong CN, Loy EY, Wong LC, Lim K, Lu JJ, Koh WY. Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era. Medicine (Baltimore). 2014 Nov;93(22):e118. doi: 10.1097/MD.0000000000000118.

3. Soon YY, Tham IW, Lim KH, Koh WY, Lu JJ. Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases. Cochrane Database Syst Rev. 2014 Mar 1;3:CD009454. doi: 10.1002/14651858.CD009454.pub2. Review.

4. Koh WY, Lim K, Tey J, Lee KM, Lim GH, Choo BA. Outcome of 6 fractions of 5.3 Gray HDR brachytherapy in combination with external beam radiotherapy for treatment of cervical cancer. Gynecol Oncol. 2013 Oct;131(1):93-8. doi: 10.1016/j.ygyno.2013.07.102. Epub 2013 Jul 29.

5. Koh WY, Ren W, Mukherjee RK, Chung HT. Internal audit of a comprehensive IMRT program for prostate cancer: a model for centers in developing countries? Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1447-54. doi: 10.1016/j.ijrobp.2008.10.010. Epub 2009 Feb 26.

6. Low JSh, Koh WY, Yap SP, Fong KW. Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience. Ann Acad Med Singapore. 2007 Sep;36(9):778-83.

7. Soon YY, Leong CN, Koh WY, Tham IW. EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis.Radiother Oncol. 2015 Feb;114(2):167-72. doi: 10.1016/j.radonc.2014.12.011. Epub 2015 Jan 9. Review.

8. Vellayappan BA, Soon YY, Earnest A, Zhang Q, Koh WY, Tham IW, Lee KM. Accuracy of (18)F-flurodeoxyglucose-positron emission tomography/computed tomography in the staging of newly diagnosed nasopharyngeal carcinoma: a systematic review and meta-analysis. Radiol Oncol. 2014 Nov 5;48(4):331-8. doi: 10.2478/raon-2014-0011. eCollection 2014 Dec.

9. Tey J, Choo BA, Leong CN, Loy EY, Wong LC, Lim K, Lu JJ, Koh WY. Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era. Medicine (Baltimore). 2014 Nov;93(22):e118. doi: 10.1097/MD.0000000000000118.

10. Soon YY, Tham IW, Lim KH, Koh WY, Lu JJ. Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases. Cochrane Database Syst Rev. 2014 Mar 1;3:CD009454. doi: 10.1002/14651858.CD009454.pub2. Review.

11. Koh WY, Lim K, Tey J, Lee KM, Lim GH, Choo BA. Outcome of 6 fractions of 5.3 Gray HDR brachytherapy in combination with external beam radiotherapy for treatment of cervical cancer. Gynecol Oncol. 2013 Oct;131(1):93-8. doi: 10.1016/j.ygyno.2013.07.102. Epub 2013 Jul 29.

12. Koh WY, Ren W, Mukherjee RK, Chung HT. Internal audit of a comprehensive IMRT program for prostate cancer: a model for centers in developing countries? Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1447-54. doi: 10.1016/j.ijrobp.2008.10.010. Epub 2009 Feb 26.

13. Low JSh, Koh WY, Yap SP, Fong KW. Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience. Ann Acad Med Singapore. 2007 Sep;36(9):778-83.